Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502

Obesity is associated with macrophage accumulation in adipose tissue

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425

A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum

Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776

Adiponectin and Adiponectin Receptors

Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,167

Polycystic ovary syndrome

Lawrence, J., Douglas, P., & Gandy, J. (2016) · doi:10.1002/9781119163411.ch73 · Cited by 1,014

Preventing and correcting polycystic ovary syndrome by targeting anti-Müllerian hormone signaling in minipuberty and adulthood in mice

Cotellessa, L., Sobrino, V., Silva, M. S. B., Delit, M., Maitre, H., Caron, É., Ternier, G., Lima, N. D. S., Lhomme, T., Giton, F., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.013 · Cited by 20

Inhibition of visfatin by FK866 mitigates pathogenesis of cystic ovary in letrozole-induced hyperandrogenised mice

Annie, L., Gurusubramanian, G., & Roy, V. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119409 · Cited by 18

Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS)

Khatun, M., Lundin, K., Naillat, F., Loog, L., Saarela, U., Tuuri, T., Salumets, A., Piltonen, T., & Tapanainen, J. S. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10627-w · Cited by 20

The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome

de Medeiros, S. F., de Medeiros, M. A. S., Barbosa, B., & Yamamoto, M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0045 · Cited by 15

Polycystic Ovary Syndrome: Is Obesity a Symptom?

Yıldız, B. O. (2013) · Women s Health · doi:10.2217/whe.13.53 · Cited by 18

Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome

Zhang, C., Li, Y., Wang, Y., Hu, S., Liu, Y., Liang, X., Chen, Z., Zhang, Y., & Zhao, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.10.038 · Cited by 17

Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications

Ni, M., Lei, H., Ye, T., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1731179 · Cited by 25

Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome

Gökcen, B. B., Akdevelıoğlu, Y., Canan, S., & Bozkurt, N. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00980-x · Cited by 17

An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome

Dumesic, D. A., Abbott, D. H., & Chazenbalk, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196120 · Cited by 17

Exercise differentially affects metabolic functions and white adipose tissue in female letrozole- and dihydrotestosterone-induced mouse models of polycystic ovary syndrome

Marcondes, R. R., Maliqueo, M. A., Fornes, R., Benrick, A., Hu, M., Ivarsson, N., Carlström, M., Cushman, S. W., Stenkula, K. G., Maciel, G. A. R., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.025 · Cited by 16

Assessing Obesity-Related Adipose Tissue Disease (OrAD) to Improve Precision Medicine for Patients Living With Obesity

Pincu, Y., Yoel, U., Haim, Y., Makarenkov, N., Maixner, N., Shaco‐Levy, R., Bashan, N., Dicker, D., & Rudich, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.860799 · Cited by 21

Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome

Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17

Key signalling pathways underlying the aetiology of polycystic ovary syndrome

Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19

Associations of Childhood Adiposity and Cardiometabolic Biomarkers With Adolescent PCOS

Whooten, R., Rifas‐Shiman, S. L., Perng, W., Chavarro, J. E., Taveras, E. M., Oken, E., & Hivert, M. (2024) · PEDIATRICS · doi:10.1542/peds.2023-064894 · Cited by 16

Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome

Oğuz, S. H., İdilman, İ. S., Helvacı, N., Guzelce, E. C., Eyüpoğlu, D., Karçaaltıncaba, M., & Yıldız, B. O. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.04.024 · Cited by 16

Role of CPXM1 in Impaired Glucose Metabolism and Ovarian Dysfunction in Polycystic Ovary Syndrome

Pervaz, S., Ullah, A., Adu‐Gyamfi, E. A., Lamptey, J., Sah, S. K., Wang, M., & Wang, Y. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00987-y · Cited by 15

Adiponectin to Leptin Ratio and its Association with Insulin Resistance in Women with Polycystic Ovarian Syndrome

Mishra, P., Mittal, P., Rani, A., Bharti, R., Agarwal, V., & Suri, J. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_137_22 · Cited by 15

Fat mass and Obesity Associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance

Parveen, S., Khan, S., Ahsan, H., Manger, P. T., Gupta, B., & Alam, R. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200174 · Cited by 17

Bioimpedance Measurements in Adolescents with Polycystic Ovary Syndrome: A Pilot Study

Geronikolou, S. A., Bacopoulou, F., & Cokkinos, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-57379-3_26 · Cited by 15

Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols

Mujica, L. K. S., Bridi, A., Mea, R. D., Rissi, V. B., Guarda, N. D. S., Moresco, R. N., Premaor, M. O., Antoniazzi, A. Q., Gonçalves, P. B. D., & Comim, F. V. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s160264 · Cited by 15

Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome

Obirikorang, C., Owiredu, W. K. B. A., Adu-Afram, S., Acheampong, E., Adu, E. A., Antwi-Boasiakoh, E. K., & Owiredu, E. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4546-z · Cited by 15

Evaluation of Para- and Perirenal Fat Thickness and its Association with Metabolic Disorders in Polycystic Ovary Syndrome

Şahin, S. B., Durakoğlugil, T., Ayaz, T., Şahin, O. Z., Durakoğlugil, M. E., Sümer, F., Aktaş, E., & Alyildiz, N. (2015) · Endocrine Practice · doi:10.4158/ep14435.or · Cited by 15

A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome

Pasquali, R., & Gambineri, A. (2015) · Women s Health · doi:10.2217/whe.15.13 · Cited by 15

Polycystic Ovary Syndrome and Obesity

Barber, T. M., Dimitriadis, G. K., & Franks, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_15 · Cited by 15

The role of immunity in insulin resistance in patients with polycystic ovary syndrome

Zhang, Q., Yang, Z., Ou, X., Zhang, M., Qin, X., & Wu, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464561 · Cited by 19

Maternal polycystic ovarian syndrome and pubertal development in daughters and sons: a population-based cohort study

Lunddorf, L. L. H., Arendt, L. H., Ernst, A., Brix, N., Knudsen, U. B., Olsen, J., & Ramlau‐Hansen, C. H. (2022) · Human Reproduction · doi:10.1093/humrep/deac197 · Cited by 14

Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS

Stener‐Victorin, E., Eriksson, G., Shrestha, M. M., Paris, V. R., Lu, H., Banks, J. L., Samad, M., Perian, C., Jude, B., Engman, V., et al. (2023) · eLife · doi:10.7554/elife.87592 · Cited by 20

Molecular role of peptides/proteins in subfertility of polycystic ovarian syndrome

Çelik, Ö., Aydın, S., Çelik, N., Uğur, K., Yavuzkır, Ş., Hatırnaz, Ş., Yardım, M., & Celik, S. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.3.5 · Cited by 14

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome

Gourgari, E., Spanakis, E. K., & Dobs, A. S. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s104825 · Cited by 14

Polycystic ovary syndrome in adolescent girls

Baldauff, N. H., & Witchel, S. F. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000309 · Cited by 14

Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network

Huang, J., Huang, B., Kong, Y., Yang, Y., Tian, C., Chen, L., Yan, L., & Ma, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032064 · Cited by 13

Fat Distribution and its Correlation with Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome

Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., & Kraemer‐Aguiar, L. G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2386-9281 · Cited by 13

Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome

Siemienowicz, K. J., Furmanska, K., Filis, P., Talia, C., Thomas, J. L., Fowler, P., Rae, M. T., & Duncan, W. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111196 · Cited by 13

Polycystic Ovary Syndrome is Associated with Elevated Periostin Levels

Chen, X., Huo, L., Ren, L., Li, Y., Sun, Y., Li, Y., Zhang, P., Chen, S., & Song, G. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0752-0061 · Cited by 13

Serum amyloid A in polycystic ovary syndrome

Liu, H., Meng, X., Wang, J., Wei, Y., Tang, J., Lei, X., He, W., & Li, S. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.03.027 · Cited by 12

Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome

Li, S., Ma, S., Yao, X., & Liu, P. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae143 · Cited by 11

Serum retinol-binding protein 4 levels in polycystic ovary syndrome

Lingaiah, S., Morin-Papunen, L. C., Piltonen, T., Poromaa, I. S., Stener‐Victorin, E., & Tapanainen, J. S. (2019) · Endocrine Connections · doi:10.1530/ec-19-0116 · Cited by 12

Polycystic ovary syndrome

Aydın, H. L., Dayan, B. S., & GÜNGÖR, N. D. (2023) · Journal of Controversies in Obstetrics & Gynecology and Pediatrics · doi:10.51271/jcogp-0015 · Cited by 12

Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice

Wu, Y., Chanclón, B., Micallef, P., Stener‐Victorin, E., Asterholm, I. W., & Benrick, A. (2021) · The FASEB Journal · doi:10.1096/fj.202002212r · Cited by 11

Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome

Tola, E. N., Karatopuk, D. U., Köroğlu, N., Ergin, M., & Oral, H. B. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-0913-7 · Cited by 11

Sex differences in androgen regulation of metabolism in nonhuman primates

True, C., Abbott, D. H., Roberts, C. T., & Varlamov, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_24 · Cited by 10

Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes

Teede, H. J., Vanky, E., Piltonen, T., Stener‐Victorin, E., Moran, L., & Khomami, M. B. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01261-w · Cited by 11

White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues

Abbasi, K., Zarezadeh, R., Valizadeh, A., Mehdizadeh, A., Hamishehkar, H., Nouri, M., & Darabi, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116012 · Cited by 12

Dapagliflozin attenuates fat accumulation and insulin resistance in obese mice with polycystic ovary syndrome

Lin, B., Guo, X., Lü, W., Niu, R. L., Zeng, X., Chen, Z., Wu, C., & Liu, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176742 · Cited by 10

Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice

Manti, M., Pui, H., Edström, S., Risal, S., Lu, H., Lindgren, E., Ohlsson, C., Jerlhag, E., Benrick, A., Deng, Q., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001060r · Cited by 10

POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation

Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2025) · Reproduction · doi:10.1530/rep-25-0021 · Cited by 11

On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome

Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 11

Is DPP4 activity increased in PCOS?

Braga, L. D. D. C., Godoy‐Matos, A. F., Siciliano, P. D. O., Corrêa, J. O. D. A., & de Carvalho, D. P. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.032 · Cited by 9

Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3

Gidwani, S., Phelan, N., McGill, J. B., McGowan, A., O’Connor, A. S., Young, I. S., Gibney, J., & McEneny, J. (2014) · Human Reproduction · doi:10.1093/humrep/deu115 · Cited by 8

Relationship of Biological Markers of Body Fat Distribution and Corticosteroidogenic Enzyme Activities in Women with Polycystic Ovary Syndrome

de Medeiros, S. F., de Medeiros, M. A. S., Barbosa, B. B., & Yamamoto, M. M. W. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0975-9207 · Cited by 8

The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women

Al-Awadi, A. M., Sarray, S., Arekat, M. R., Saleh, L. R., Mahmood, N., & Almawi, W. Y. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.03.078 · Cited by 8

Electroacupuncture improves follicular development and metabolism and regulates the expression of adiponectin, AMPK and ACC in an obese rat model of polycystic ovary syndrome

Zhou, J., Yin, P., Zhao, Q., Hu, Z., Wang, Y., Ma, G., Wu, X., Lu, L., & Shi, Y. (2022) · Acupuncture in Medicine · doi:10.1177/09645284221107690 · Cited by 7

Activating transcriptional factor 4 correlated with obesity and insulin resistance in polycystic ovary syndrome

Di, F., Liu, J., Li, S., Hong, Y., Chen, Z., & Du, Y. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1527307 · Cited by 7

Adiponectin/leptin and HOMA/adiponectin ratios in Iranian women with polycystic ovary syndrome

Vatannejad, A., & Kheirollahi, A. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03408-4 · Cited by 7

The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel.

Jakubowicz, D. J., Wainstein, J., & Homburg, R. (2012) · PubMed · Cited by 7

Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome

Aubuchon, M., Bickhaus, J. A., & González, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_8 · Cited by 7

Contributions of white adipose tissue to energy requirements for female reproduction

Anaya, E. S., de Groot, E. L., Lydon, J. P., Pangas, S. A., & Hartig, S. M. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.012 · Cited by 7

Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome

Tinano, F. R., Machado, I. F. R., Latronico, A. C., & Gomes, L. G. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1681-24.2024 · Cited by 8

Higher Visceral and Lower Peripheral Adiposity Characterize Fat Distribution and Insulin Resistance in Asian Indian Women with Polycystic Ovary Syndrome in Mauritius

Ramessur, V., Hunma, S., Joonas, N., Ramessur, B. N., Schütz, Y., Montani, J., & Dulloo, A. G. (2025) · Obesity Facts · doi:10.1159/000543332 · Cited by 8

Body composition of lean women with polycystic ovary syndrome

Zabulienė, L., Urbonienė, J., & Tutkuvienė, J. (2013) · Anthropological Review · doi:10.2478/anre-2013-0018 · Cited by 6

Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor‐induced rat model of polycystic ovary syndrome

Maliqueo, M. A., Benrick, A., Marcondes, R. R., Johansson, J., Sun, M., & Stener‐Victorin, E. (2016) · Experimental Physiology · doi:10.1113/ep085983 · Cited by 6

Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences

Bellanger, S., Battista, M., & Baillargeon, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_7 · Cited by 5

Adiponectin Receptor Agonist AdipoRon Ameliorates the Metabolic Complications in a Hyperandrogenic Rat Model of PCOS

Abdelhameed, A. M., Eissa, M., Thompson, K., Edwards, K. S., Hoang, N., Rezq, S., Cornelius, D. C., Romero, D. G., & Cardozo, L. L. Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf173 · Cited by 4

Androgen actions in metabolic tissues in polycystic ovary syndrome

MacRae, C. L., & Campbell, R. E. (2026) · Endocrinology · doi:10.1210/endocr/bqag001 · Cited by 5

MASLD, diabetes and PMOS across the female life stages

Stener‐Victorin, E., Carlsson, S., Hagström, H., & Taebnia, N. (2026) · Diabetologia · doi:10.1007/s00125-026-06761-y · Cited by 7

Insight into the pathogensis of polycystic ovarian syndrome

Jung, Y. W., Lee, G. H., Han, Y. J., & Cha, D. H. (2020) · Journal of genetic medicine · doi:10.5734/jgm.2020.17.1.1 · Cited by 5

The relationship between prolactin and adipose tissue and metabolic parameters in patients with polycystic ovary syndrome

Aydın, G. A., & Özsoy, H. G. T. (2020) · The European Research Journal · doi:10.18621/eurj.668471 · Cited by 5

Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome

Yang, J., Lin, M., Tian, X., Li, C., Wu, H., Deng, L., Xue-lan, L., & Chen, X. (2024) · Endocrine Connections · doi:10.1530/ec-24-0401 · Cited by 11

Autoimmune Processes and Chronic Inflammation as Independent Risk Factors for Metabolic Complications in Women with Polycystic Ovary Syndrome

Suchta, K., Żeber‐Lubecka, N., Grymowicz, M., Smolarczyk, R., Kulecka, M., & Hennig, E. E. (2025) · Metabolites · doi:10.3390/metabo15030141 · Cited by 5

Brain‐Specific Gata4 Downregulation in Greywick Female Mice Models the Metabolic Subtype of Polycystic Ovary Syndrome

Nawaito, S. A., Esmael, M., Souchkova, O., Cardinal, T., Bernas, G., Bergeron, K., Gayda, F., Bergeron, F., Bouchard, M., Zhou, X., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202401718rr · Cited by 5

Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention

Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5

Polycystic Ovary Syndrome (PCOS)

Hechtman, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00209-0 · Cited by 6

Comparative Meta-analysis of Adipose Tissue Transcriptomics Data in PCOS Patients and Healthy Control Women

Saedi, S., Panahi, R., Orak, N., & Shirazi, M. R. J. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01145-0 · Cited by 5

Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS

Binder, A. K., Peecher, D. L., Qvigstad, A. J., Gutierrez, S. D., Magana, J., Banks, D. B., & Korach, K. S. (2023) · Endocrinology · doi:10.1210/endocr/bqad024 · Cited by 5

Protective Effect of Marjoram Against Letrozole-Induced Ovarian Damage in Rats with Polycystic Ovarian Syndrome Entails Activation of Nrf2 and Suppression of NF-κB

Al‐Harbi, L. N., AlSedairy, S. A., Alshammari, G. M., Binobead, M. A., & Arzoo, S. (2025) · Pharmaceuticals · doi:10.3390/ph18091291 · Cited by 7

Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives

Liu, S., Wang, R., Yu, W., Shi, C., Wang, X., Liu, A., & Zhang, L. (2026) · Nutrients · doi:10.3390/nu18060964 · Cited by 5

Elevated circulating adiponectin levels do not prevent anxiety-like behavior in a PCOS-like mouse model

Samad, M., Ek, C. J., Börchers, S., Krieger, J.-P., Stener‐Victorin, E., Skibicka, K. P., Asterholm, I. W., & Benrick, A. (2024) · Scientific Reports · doi:10.1038/s41598-023-50503-8 · Cited by 4

Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome

Hellberg, A., Salamon, D., Ujvári, D., Rydén, M., & Hirschberg, A. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111566 · Cited by 4

The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome

Tımur, H., Yimaz, N., Kahyaoğlu, İ., İnal, H. A., & Erkaya, S. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0582-3 · Cited by 4

The impact of serum visfatin, and resistin levels on insulin resistance in patients with polycystic ovary syndrome

Moustafa, S. R., & Al‐Hakeim, H. K. (2020) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2020.011 · Cited by 4

Intrinsic abnormalities of adipose tissue and adipose tissue dysfunction in PCOS

Spritzer, P. M., dos Santos, B. R., Fighera, T. M., Marchesan, L. B., & Lecke, S. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00005-5 · Cited by 4

Western‐style diet in the presence of elevated circulating testosterone induces adipocyte hypertrophy without proinflammatory responses in rhesus macaques

Burwitz, B. J., Yusova, S., Robino, J. J., Takahashi, D. L., Luo, A., Slayden, O. D., Bishop, C. V., Hennebold, J. D., Roberts, C. T., & Varlamov, O. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13773 · Cited by 4

Plasmatic free light chains in polycystic ovary syndrome

Mancini, A., Brunetti, A., Bruno, C., Vergani, E., Pocino, K., Napodano, C., Gulli, F., Santini, S. A., & Basile, U. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1581759 · Cited by 4

Obesity in polycystic ovary syndrome and infertility

Messinis, I. E., Messini, C. I., & Dafopoulos, K. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00003-6 · Cited by 4

Exploring the Combination of Traditional Chinese and Allopathic Medicine in the Treatment of Polycystic Ovary Syndrome from the Perspective of Modern Medicine

Hu, X., Zhu, M., Zhou, Q., Li, Z., Luo, L., Liang, W., Chen, S., Pu, X., & Du, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s574929 · Cited by 4

Orosomucoid 2 improves reproductive phenotypes in a mouse model of PCOS induced by letrozole under high-fat diet conditions

Xu, Q., Qiu, S., Wang, L., Liu, Y., Lu, Y., Wu, L., & Zhang, J. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag005 · Cited by 3

The polycystic ovary syndrome: a position statement from the European Society of

Conway, G. S., Dewailly, D., Diamanti‐Kandarakis, E., Franks, S., Gambineri, A., Keleştimur, F., Μacut, D., Micić, D., Pasquali, R., Pfeifer, M., et al. (2014) · Cited by 3

Hypertension Predisposition and Thermoregulation Delays in Adolescents with Polycystic Ovary Syndrome: A Pilot Study

Geronikolou, S. A., Bacopoulou, F., Chryssanthopoulos, S., Cokkinos, D. V., & Chrousos, G. P. (2022) · Children · doi:10.3390/children9030316 · Cited by 3

Polycystic Ovary Syndrome: Current Approaches to the Problem (Literature Review)

Можейко, Л. Ф., & Потоцкая, А. А. (2022) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2022.12.3.010 · Cited by 3

Precision Nutrition in Female Reproductive Health

Dumesic, D. A., Chazenbalk, G. D., & Heber, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00002-x · Cited by 3

Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome

Ezeh, U. I., Chen, Y. I., Pall, M., Buyalos, R. P., Chan, J. L., Pisarska, M. D., & Azziz, R. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.030 · Cited by 6

Transcriptome Analysis of Mesenchymal Progenitor Cells Revealed Molecular Insights into Metabolic Dysfunction and Inflammation in Polycystic Ovary Syndrome

Huang, M.-C., Chen, P., & Hsu, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147948 · Cited by 3

Shortened Relative Leukocyte Telomere Length Is Associated With Polycystic Ovary Syndrome and Metabolic Traits

Chan, R. N. C., Huang, C., Ng, N. Y. H., Tam, H. C. H., Tam, C. H. T., Cheng, F., Wong, K. K., Shi, M., Ng, A. C. W., Tsang, A. Y. T., et al. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70030 · Cited by 3

Androgen Receptor PROTAC ARV-110 Ameliorates Metabolic Complications in a Mouse Model of Polycystic Ovary Syndrome

Basnet, J., Rezq, S., Huffman, A. M., Asala, T. E., Cardozo, L. L. Y., & Romero, D. G. (2025) · Endocrinology · doi:10.1210/endocr/bqaf091 · Cited by 2

Free lipid and computerized determination of adipocyte size

Svensson, H. G., Olausson, D., Holmäng, A. B., Jennische, E., Edén, S., & Lönn, M. (2018) · Adipocyte · doi:10.1080/21623945.2018.1489335 · Cited by 4

Obesity in PCOS and Infertility

Messinis, I. E., Messini, C. I., & Dafopoulos, K. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00008-x · Cited by 3

Proteomic analysis shows decreased Type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOSPreprint

Stener‐Victorin, E., Eriksson, G., Shrestha, M. M., Paris, V. R., Lu, H., Banks, J. L., Samad, M., Perian, C., Jude, B., Engman, V., et al. (2023) · medRxiv · doi:10.1101/2023.03.08.23286896 · Cited by 3

Metabolic Implications of PCOS

Naveed, A., Shah, R., Bernier, A., Muradova, V., Gurol, E. S., Cree‐Green, M., & Whooten, R. (2025) · Current Pediatrics Reports · doi:10.1007/s40124-025-00364-8 · Cited by 2

Relationship Between Adipose Tissue and Liver Dysfunction in Women with Polycystic Ovary Syndrome and Metabolic Syndrome

de Medeiros, S. F., & Maciel, G. A. R. (2026) · Metabolites · doi:10.3390/metabo16060393 · Cited by 3

The pathogenic role of androgen excess in PCOS

Pignatelli, D., Pereira, S. S., & Kandaraki, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00017-1 · Cited by 4

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome

Spranger, J., Möhlig, M., Wegewitz, U. E., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Brabant, G. E., & Schöfl, C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02159.x · Cited by 130

Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome

Morrison, S. A., Goss, A. M., Azziz, R., Raju, D. A., & Gower, B. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew279 · Cited by 21

High-Molecular-Weight Adiponectin Is Selectively Reduced in Women with Polycystic Ovary Syndrome Independent of Body Mass Index and Severity of Insulin Resistance

O’Connor, A. S., Phelan, N., Tun, T. K., Boran, G. P., Gibney, J., & Roche, H. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1557 · Cited by 81

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome

Ardawi, M. S. M., & Rouzi, A. A. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.077 · Cited by 165

Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity

Aydoğdu, A., Taşçı, İ., Küçükerdönmez, Ö., Tapan, S., Aydogdu, S., Aydoğan, Ü., Sönmez, A., Yazıcı, M., & Azal, Ö. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.708802 · Cited by 14